chitosan has been researched along with Psoriasis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 8 (72.73) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, SA | 2 |
| Fu, S; Lai, R; Liu, Z; Lu, Y; Luo, W; Wang, Y; Xu, Y | 1 |
| Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, S | 1 |
| Al-Nemrawi, NK; Alzoubi, KH; Khafajah, AS | 1 |
| Abourehab, MAS; Hazari, SA; Kesharwani, P; Sheikh, A; Tulbah, AS | 1 |
| Pu, S; Sun, L; Zhao, K; Zhou, D | 1 |
| Alshehri, SA; Hazari, SA; Kesharwani, P; Molugulu, N; Sahebkar, A; Sheikh, A; Wahab, S | 1 |
| Adame, S; Adhami, VM; Babatunde, AS; Bharali, DJ; Chamcheu, JC; Esnault, S; Longley, BJ; Massey, RJ; Mousa, SA; Mukhtar, H; Siddiqui, IA; Wood, GS | 1 |
| Gomez, C; Muangnoi, C; Rojsitthisak, P; Sorasitthiyanukarn, FN; Wongpiyabovorn, J | 1 |
| Bonferoni, MC; Catanzaro, M; Faccendini, A; Ferrari, F; Lanni, C; Malavasi, L; Malgarim Cordenonsi, L; Platcheck Raffin, R; Rossi, S; Sandri, G; Scherman Schapoval, EE | 1 |
11 other study(ies) available for chitosan and Psoriasis
| Article | Year |
|---|---|
Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis.
Topics: Animals; Chitosan; Drug Carriers; Lecithins; Mice; Nanoparticles; Particle Size; Psoriasis; Tacrolimus | 2021 |
Chitosan/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: A combined chemo-photodynamic therapy for psoriasis.
Topics: Aminolevulinic Acid; Cell Line; Chitosan; Drug Therapy, Combination; Humans; Hyaluronic Acid; Levulinic Acids; Lipopolysaccharides; Methotrexate; Nanogels; Photosensitizing Agents; Psoriasis | 2022 |
Boosting the anti-inflammatory effect of self-assembled hybrid lecithin-chitosan nanoparticles via hybridization with gold nanoparticles for the treatment of psoriasis: elemental mapping and
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Gold; Lecithins; Metal Nanoparticles; Mice; Psoriasis; Tacrolimus | 2022 |
Novel Chitosan Nanoparticles Loaded with Methotrexate for Topical Treatment of Psoriasis.
Topics: Animals; Chitosan; Methotrexate; Mice; Nanoparticles; Psoriasis; Rats; Skin | 2023 |
Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis.
Topics: Chitosan; Gallic Acid; Humans; Imiquimod; Lecithins; Nanoparticles; Particle Size; Psoriasis | 2023 |
Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
Topics: Animals; Cell Proliferation; Chitosan; Dermatitis; Disease Models, Animal; Imiquimod; Inflammation; Interleukin-17; Interleukin-6; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2023 |
Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis.
Topics: Chitosan; Gallic Acid; Humans; Hyaluronic Acid; Nanoparticles; Psoriasis | 2023 |
Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
Topics: Administration, Cutaneous; Animals; Chitosan; Drug Carriers; Drug Liberation; Ear; Imiquimod; Immunosuppressive Agents; Mice, Inbred C57BL; Nanoparticles; Particle Size; Psoriasis; Rats, Sprague-Dawley; Skin; Tacrolimus | 2021 |
Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Antioxidants; Catechin; Cell Differentiation; Cells, Cultured; Chitosan; Dermatitis; Filaggrin Proteins; Humans; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis | 2018 |
Synergistic Effects of Photo-Irradiation and Curcumin-Chitosan/Alginate Nanoparticles on Tumor Necrosis Factor-Alpha-Induced Psoriasis-Like Proliferation of Keratinocytes.
Topics: Alginates; Cell Line, Transformed; Cell Proliferation; Chitosan; Curcumin; Drug Delivery Systems; Humans; Keratinocytes; Light; Nanoparticles; Psoriasis; Tumor Necrosis Factor-alpha | 2019 |
The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin.
Topics: Administration, Cutaneous; Cell Line; Cell Survival; Chitosan; Drug Carriers; Fibroblasts; Humans; Lipids; Nanostructures; Psoriasis; Xanthophylls | 2019 |